
Medical Affairs Clinical Research Advisor
Porto Salvo, 葡萄牙 Permanent Posted on Feb. 21, 2025 Closing on Mar. 21, 2025- Job title: Medical Affairs Clinical Research Advisor
- Location: Lisbon (Portugal)
MISSION:
The main mission of the Medical Affairs Clinical Research Advisor (MACRA) in Portugal is to:
− Capture the R&D, Medical Affairs, and local Business Units needs, to ensure transversal alignment for the conduct of Clinical Trials in Portugal.
− Support the local R&D activity in Portugal in alignment with the Iberic CSU Cluster Head. The MACRA is the main Point of Contact in the Portuguese Affiliate for any clinical trial related activity with:
- Iberic CSU Leadership Team
- CSU Medical Advisors
- Clinical Project Leaders (CPL)
- Site Partnership Manager (SPM)
- CTA Regulatory Manager (CTARM)
- Any other CSU team member, as needed
− The MACRA is a key person which represents Sanofi R&D in front of external stakeholders in Portugal
− Ensure the traceability of the R&D investments performed in Portugal
RESPONSIBILITIES:
Medical Affairs, Business Units, and supporting the CSU functions
- Regulatory activities:
- Be the contact person with Iberic Cluster CTARM
- Responsible for updating/ allerting the CTARM on any new Regulatory requirement for Clinical Trial (CT) submission to Health Authority (INFARMED/Central Ethics Committee (EC), when applicable.
- Participate in the regulatory/ ad hoc regulatory meetings aimed to review the status of studies conducted in Portugal
- Attendance to Set-up meetings of studies conducted in Portugal
- Interfacing with Health Authorities and Central Ethic Committee and being the bridge with the Iberic CTARM, when needed (e.g. for clarifications)
- Support the validation of glossary in Portugal (LRA for IP labels)
- Main contact for APIFARMA
- Taking part in the Pharmaceutical Association (APIFARMA) meetings related to Clinical Studies.
- Distributing the APIFARMA Newsletter as needed to the proper stakeholders.
- Clinical Trial Delivery:
- Being aligned with the CT priorities and committed targets, end to end (E2E).
- Attendance/ participation in Operational Feasibility Meetings
- Site Partnership Management activities:
- Acting as liaison/contact person with the Iberic Cluster SPM in Portugal
- Maintaining and actively contribute to the site identification list agreed with SPM and Medical Advisors and aligned with portfolio and country strategy
- In liaison with CSU CPL, support sites on requests and prompt resolutions to achieve Sanofi standards
- Develop a network of Sites and Investigators to ensure a relevant analysis of study feasibility and execution together with the Cluster Medical Advisors
- Financial Agreement activities:
- Acting as liaison/contact person with Contract Specialists and Legal Department for Clinical Studies
- Acting as liaison/contact person and supporting the CSU Quality Lead.
- Safety activities: Support Iberic Cluster Safety Lead
- IP activities: Support for local depot management
- Facilities / Archiving room: in alignment with facilities management, acting as liaison/contact person with the local PT team, as needed
- For R&D outsourced studies, contribute with key Sanofi stakeholders to ensure that CRO partners are properly leveraging and interacting with the participating sites
- Fully accountable for Portugal R&D invoicing in alignment with Finance controller and EU Alliance Manager:
- Launch Local PO in eBUY
- Ensure the vendor includes in the invoices all the information needed to be stated in the monthly fees bill: split per project, per phase or any other details or statements that are required
- Track Portugal invoices and validate them
- Gather and handle the necessary data and documentation related to the R&D investment to ensure E2E execution of the necessary processes, supporting the finance controller needs
- Support preparation of Tax Rebate audits
Medical Affairs activities:
- Ensures strong interaction with CSU Cluster, transversal Medical Affairs and Business Unit for KOLs management contributing to study execution
- Support the identification of the next generation of Investigators and KOLs
- Contribute to strategic interaction with Medical & Scientific departments for KOLs and expert’s management.
- Share regularly the study projects scheduled and the status of the studies within the affiliate.
- Participation in local key Medical Congresses, Symposiums, Product Launches
- Develop local awareness and education when Sanofi enters new therapeutic areas
KEY WORKING RELATIONSHIPS:
Hierarchic / Functional dependence: Medical Country Lead
- Internal: CSU Leadership team, Clinical Project Leaders, CSU Medical Advisors, Medical Leads & Medical Advisors, local Pharmacovigilance, Public Affairs and Advocacy Representative
- External: APIFARMA, Health Authorities (INFARMED and others), ECs, KOLs, potential investigators & investigational study sites, CROs, Scientific Societies, Patient Advocacy Groups and others
SKILLS, EXPERIENCE & KNOWLEDGE REQUIREMENTS:
Background: LifeScience Degree is mandatory (Medicine; Pharmaceutical, or other)
Professional experience: minimum 4 years’ experience in Clinical Research is essential, trained on Good Clinical Practices. Mandatory, minimum two years’ experience in Clinical Studies Management. Experience in Medical affairs is a plus
Knowledge:
- Highly knowledgeable in Investigator site management, clinical trial operations, study development, EMA Regulations and ICH/GCP guidelines
- Understanding of study start up complexities, RBM and overall Sponsor /site dynamics
- ICH – GCP and regulatory and safety regulations (local and European). Local and Corporate SOPs
- Good knowledge of the pharmaceutical industry and healthcare systems within the country
- Solid scientific background
Language: (language and knowledge level): Portuguese native language, English Advanced fluent in written & spoken, some domain of Spanish language is a plus
COMPETENCY REQUIREMENTS:
-Good scientific communication skills
-Effective team communicator that promotes transversal collaboration and Team work spirit
-Strategic thinking & problem solving
-Team training
-Proactivity & accountability mindset
-Ability to set priorities
-Analytic & Accuracy ability
-Strong social and influencing skills
-Optimistic, committed, dynamic, organized and results driven
-Competencies PLAY TO WIN:
-Stretch to go beyond the level we have operated at up until now
-Act in the interest of our patients and customers
-Take action instead of waiting to be told what to do
-Put the interests of the organization ahead of my own or those of our team
Why choose us?
- Bring the miracles of science to life alongside a supportive, future-focused team.
- Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.
- Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.
- Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare,
Pursue progress, discover extraordinary
Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.
At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, or gender identity.
Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com
追寻 发展。探索 菲凡。
进步需要我们每个人的参与——不论其背景、地域、或职业,我们都有一个共同的愿望:创造奇迹。你也可以成为其中的一员。我们不断追求变革,拥抱新思想,探索我们所能提供的一切机会。让我们一起追求进步。共同发现非凡。
在赛诺菲,不分种族、肤色、血统、宗教、性别、国籍、性取向、年龄、公民身份、婚姻状况、残疾或性别认同,我们为所有人提供平等的机会。
观看 “在赛诺菲的一天” ,并在官网 (sanofi.com) 上查看赛诺菲的多元化、公平与包容倡议!

查看所有职
我们的产品设计师负责帮助人们提高免疫力,物流专家负责将药物送到需要的人手中,而数据分析师则借助先进的技术改善人们的生活。在医疗健康领域,每一次进步都离不开所有人的努力。您可以自由选择自己的职业发展道路。Gig零工项目将帮助您尝试更多岗位,个性化指导将为您挖掘自己从未被发现的优势。加入我们,开启菲凡的职业发展之路。您到底可以走多远?让我们拭目以待!
体验可能性
-
Ama
Ama puts her project management techniques and ServiceNow knowledge to use to help advance Sanofi’s Digital Data operating model. Learn how our team connects data and AI to do what’s never been done before.
-
Cambridge Crossing
We're bringing together 2,500 people from across our organization — R&D, Medical, Commercial and Global colleagues all working to realize the power of collaboration.
-
Innovation in Action
Our flexible lab of the future will transform how we conduct research, while our innovation center will be fully integrated with existing R&D locations.
-
Sanofi’s AI Centre of Excellence in Toronto
The Centre is focused on using leading technologies to develop world-class data and artificial intelligence (AI) products to create value for the health sector.
-
Sanofi Canada's Philanthropic Efforts
By chasing the miracles of science to improve people’s lives, we surprise ourselves with what we can achieve. Our team is humbled by the impact our efforts make.
-
Sustainable and Green
Our new facility was built to minimize the environmental impact — helping protect our planet and people. Using resources efficiently, we're providing greener, healthier workspaces.
-
-
-
我们的办公地点
我们的员工遍布60多个国家/地区。他们勠力同心,携手共创医疗健康领域的美好未来。无论您在哪里工作,我们的专家都会指导您推动职业发展,您也将能够运用先进的科学技术,取得意义非凡的重大突破。
-
勇敢追梦,奔赴美好未来
想要改变自己的生活,乃至改变全球数百万人的生活,该怎么做?加入我们,开启职业新篇章,然后在我们的保驾护航中展翅高飞,并向优秀的人求教,为这份事业做出切实的贡献。
-
您和我们相互依存,共同成长
我们精心打造薪酬体系,为您的身心健康、财务健康与社交健康提供全面保障。我们有着海纳百川的包容性团队文化,无论您在哪个岗位,都能展翅高飞。
-
心怀梦想,成就一番事业
我们希望您以饱满的热情投入到自己的工作岗位中,给全球数百万人带来美好生活。您的职业发展道路由您自己来掌控。您只管制定目标,我们会提供充足的培训机会和支持,让您得偿所愿。
-
我们的人与文化
我们是首个建立多元化、公平性和包容性(DE&I)委员会的制药企业。我们还建立了“菲常联盟”,为每位员工提供发声的平台。您的声音是我们建设未来道路的重要基石。
-
我们的故事
我们关注每一个员工的声音。因为,我们的未来取决于所有员工的付出与努力。正因为他们的助力,我们才能追求远大的理想。
-
为什么选择我们?
我们为您提供各种工具、支持和培训机会,帮助您实现自己的目标。我们也希望您充分发挥潜力,帮助我们实现目标:将新药研发到临床治疗的时间减半。